EFSA, Stakeholder Meeting on the Safety of Caffeine

Posted By: Selerant RSA


The European Food Safety Authority (EFSA) will present its draft opinion on the safety of caffeine at a scientific meeting on 5 March, 2015.

EFSA's Nutrition Unit has launched an open consultation until 15 March 2015 on the draft scientific opinion on the safety of caffeine. This document addresses concerns raised in relation to caffeine consumption in the following circumstances and age groups:

  • caffeine consumption during pregnancy, and adverse health effects on the fetus;
  • acute and long-term effects of caffeine consumption on the central nervous system in adults, adolescents, and children;
  • long-term adverse effects of caffeine consumption on the cardiovascular system in adults;
  • acute effects of caffeine consumption in “energy drinks” and risk of adverse health effects in adolescents and adults involving the cardiovascular and central nervous systems, particularly when consumed within short periods of time, at high doses, and in combination with alcohol and/or physical exercise;
  • acute effects of caffeine in combination with synephrine on the cardiovascular system.

Moreover the draft opinion finds also that “single doses of caffeine up to 200 mg and daily intakes of up to 400 mg do not raise safety concerns for adults.”

The meeting aims to bring together interested parties from national and international risk assessment bodies, academia, consumer organizations, and food sector operations.

Comments on the draft scientific opinion on the safety of caffeine can be provided either before or after this meeting but not later than 15 March 2015. Please use the electronic template provided on EFSA website.